| Name: |
Kapil D. Sethi
|
| Affiliation: | Professor, Department of Neurology, Medical College of Georgia |
| | Associate Professor, Neurology, Medical College of Georgia |
| Degree(s): | M.D.; MD; MBBS; F.R.C.P. (UK) | | Communities: | Neurology, Clinical Medicine | Scholar Network:
(What's this) | 13 Co-Authors
345 2nd Level Co-Authors
5362 3rd Level Co-Authors
42 Departmental Colleagues |
| Expertise: |
Parkinson's Disease and Movement Disorders.
|
|
|
Additional information not available via this concise profile:
- Contact Information
- 25 Additional Publications
- Funding Received
- 13 Co-Author Profiles
- Professional Memberships
|
|
Partial
Publication List
"The impact of levodopa on quality of life in patients with Parkinson disease." The neurologist 16, No. 2 2010, pp. 76-83.
Sethi, Kapil D | | From Abstract: | | BACKGROUND: Parkinson disease (PD) is associated with a progressive decline in patient quality of life (QoL), because of motor and nonmotor manifestations of PD and treatment-related side effects... an adverse impact on QoL. CONCLUSIONS: Levodopa (LD; combined with carbidopa) remains the gold standard |
| "Dystonia in spinocerebellar ataxia type 6." Movement disorders : official journal of the Movement Disorder Society 17, No. 1 2002, pp. 150-3.
Sethi, Kapil D; Jankovic, Joseph | | From Abstract: | | with a paucity of other manifestations including extrapyramidal findings. We report on two patients with genetically proven SCA-6 who had dystonia. One patient presented initially with dystonia, which remained |
| "Botulinum toxin treatment of painful tonic spasms in multiple sclerosis." Neurology 62, No. 11 2004, p. 2143; author reply 2143.
Morgan, John C; Hess, David C; Sethi, Kapil D |
| "Botulinum toxin A during pregnancy: a survey of treating physicians" Journal of Neurology, Neurosurgery and Psychiatry 77, No. 1 2006, pp. 117-119.
Morgan, J. C.; Iyer, S. S.; Moser, E. T.; Singer, C.; Sethi, K. D. | | From Abstract: | | trimester, and only one patient, who had prior spontaneous abortions, suffered a miscarriage. Another... that physicians and patients carefully consider the risks and benefits before using btxA in pregnant |
| "Levodopa unresponsive symptoms in Parkinson disease." Movement disorders : official journal of the Movement Disorder Society 23 Suppl 3 2008, pp. S521-33.
Sethi, Kapil | | From Abstract: | | Levodopa has been the mainstay of symptomatic therapy for Parkinson Disease (PD) for 40 years providing benefit to virtually all patients. Levodopa therapy results in improved activities of daily living, enhanced quality of life, and improved mortality. However, the long-term use of levodopa |
|
Welcome: Guest
| Login
|
Help
| 
